| Financial Year |
March 31 2023 |
| Monetary Funds |
275,173,482.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,861,191.56 |
| Accounts Receivable |
433,894,599.45 |
| Advances to Suppliers |
39,127,844.06 |
| Other Receivables |
1,937,135.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
553,910,592.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
76,299,615.29 |
| Total Current Assets |
1,394,651,793.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,373,577,482.90 |
| Under-construction Projects |
292,624,730.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
134,170,253.98 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,067,878.72 |
| Deferred Income Tax Assets |
42,888,338.14 |
| Other Non-Current Assets |
52,813,528.07 |
| Sub-Total of Non-Current Assets |
1,903,755,128.56 |
| Total Assets |
3,298,406,922.37 |
| Short-Term Loans |
334,100,082.33 |
| Trading Financial liabilities |
44,800.00 |
| Notes Payable |
371,546,042.80 |
| Accounts Payable |
445,500,373.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,110,965.43 |
| Taxes Payable |
3,972,042.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,872,920.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
66,289,729.71 |
| Sub-Total of Current Liabilities |
1,320,333,125.09 |
| Long-term Loans |
240,142,695.83 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
25,372,287.46 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
741,995.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
280,843,762.97 |
| Total Liabilities |
1,601,176,888.06 |
| Paid-In Capital(Or Share Stock) |
142,480,000.00 |
| Capital Surplus |
808,862,975.63 |
| Surplus Reserve |
43,445,336.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
700,240,483.07 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,697,230,034.31 |
| Owner's Equity（Stockholder's Equity） |
1,697,230,034.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,298,406,922.37 |
